Related Experiment Videos

Growth hormone responses to growth hormone releasing factor in neonates

Biology of the Neonate
|January 1, 1985
PubMed

Insights

Synthetic human growth hormone releasing factor (hGRF) effectively stimulates growth hormone (GH) release in neonates. No significant differences in GH response were observed across various neonatal subgroups based on age, gestational age, birth weight, or sex.

Area of Science:

  • Neonatal endocrinology
  • Pediatric growth disorders

Background:

  • Growth hormone (GH) is crucial for neonatal development.
  • Understanding GH regulation in neonates is vital for diagnosing and treating growth impairments.

Purpose of the Study:

  • To assess the acute secretory response of GH to synthetic human growth hormone releasing factor (hGRF) in neonates.
  • To investigate potential demographic or physiological factors influencing this response.

Main Methods:

  • Intravenous administration of synthetic hGRF to 32 neonates (3-28 days old).
  • Measurement of serum GH levels at baseline and at 30-minute intervals post-administration.
  • Statistical comparison of GH response across subgroups (age, gestational age, birth weight, sex).

Main Results:

  • GH levels peaked at 30 minutes after hGRF administration, reaching a mean of 66.4 +/- 6.2 ng/ml.
  • No statistically significant differences in GH response were found when comparing neonates based on age (<7 vs. >8 days), gestational age (<37 vs. >38 weeks), birth weight (<2,500g vs. >2,501g), or sex.

Conclusions:

  • Synthetic hGRF reliably stimulates GH release in neonates.
  • The neonatal GH response to hGRF is consistent across a range of early developmental parameters, suggesting a robust and uniform hypothalamic-pituitary axis function in this age group.

Related Concept Videos